Trial · NCT07140484
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Lung diffusing capacity | 6 weeks post starting treatment | Lung diffusing capacity (DLCO) will be measured using six-second, advanced DLCO techniques |
| Primary | Lung diffusing capacity | 23 weeks post starting treatment | Lung diffusing capacity (DLCO) will be measured using six-second, advanced DLCO techniques |
| Primary | Diffusing membrane capacity (Dm) | 6 weeks post starting treatment | Diffusing membrane capacity will be measured using six-second, advanced DLCO |
| Primary | Diffusing membrane capacity (Dm) | 23 weeks post starting treatment | Diffusing membrane capacity will be measured using six-second, advanced DLCO |
| Primary | Pulmonary capillary blood volume (Vc) | 6 weeks post starting treatment | Pulmonary capillary blood volume (Vc) will be measured using six-second, advanced DLCO techniques |
| Primary | Pulmonary capillary blood volume (Vc) | 23 weeks post starting treatment | Pulmonary capillary blood volume (Vc) will be measured using six-second, advanced DLCO techniques |
| Secondary | Cardiac structure and function | 6 weeks post starting treatment | Cardiac structure will be measured using standard cardiac ultrasound |
| Secondary | Cardiac structure and function | 23 weeks post starting treatment | Cardiac structure will be measured using standard cardiac ultrasound |
| Secondary | Cardiac function | 6 weeks post starting treatment | Cardiac function will be measured using standard cardiac ultrasound |
| Secondary | Cardiac function | 23 weeks post starting treatment | Cardiac function will be measured using standard cardiac ultrasound |
| Secondary | Peripheral muscle microcirculation | 6 weeks post starting treatment | Peripheral muscle microcirculation will be measured using continuous-wave near-infrared spectroscopy |
| Secondary | Peripheral muscle microcirculation | 23 weeks post starting treatment | Peripheral muscle microcirculation will be measured using continuous-wave near-infrared spectroscopy |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07140484/registered